Plessier A et al. (2006) Aiming at minimal invasiveness as a therapeutic strategy for Budd–Chiari syndrome. Hepatology 44: 1308–1316
Occlusion of the inferior vena cava or hepatic vein causes Budd–Chiari syndrome (BCS), which can lead to liver failure. BCS has a 1-year spontaneous mortality rate reported to approach 70%, and many treatments have been proposed for the condition. Plessier et al. report on their strategy of commencing therapy with the least-invasive treatment, followed by successively more-invasive procedures in patients who do not respond. Use of this strategy in 51 consecutive patients who presented with BCS produced overall 1-year, 3-year and 5-year survival rates of 96%, 89%, and 89%, respectively.
Anticoagulation therapy was the first-line treatment; a complete response was obtained in nine patients, and one patient died of hematologic disease. Recanalization was carried out in the 14 patients who had an adequately short stenosis; this procedure resulted in a complete response in 7 patients. Of the remaining 34 patients, 25 were suitable for transjugular intrahepatic portal shunt placement; this intervention was successful in 21 patients, although 1 required transplantation 4 months later. Two patients died from procedure-related complications. The remaining 11 patients underwent liver transplantation (median time from anticoagulation initiation, 12 months), 1 of whom died from sepsis. In total, 5 of the 51 patients who commenced treatment died.
The authors conclude that a strategy of increasing the invasiveness of treatment according to patient responses produces excellent medium-term survival rates. The liver-transplant success rate suggests that performing transplantation only when other interventions have failed does not compromise patient survival.
Rights and permissions
About this article
Cite this article
Minimally invasive treatment strategy for Budd–Chiari syndrome. Nat Rev Gastroenterol Hepatol 4, 65 (2007). https://doi.org/10.1038/ncpgasthep0707
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0707